Skip to Content

Biosyntech Inc BSYI Stock Quote

| Rating as of

PINX:BSYI

Morningstar‘s Stock Analysis BSYI

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics BSYI

Company Profile BSYI

Business Description

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Contact
475 Boulevard Armand-Frappier
Laval, QC, H7V 4B3, Canada
T +1 450 686-2437
Industry Biotechnology
Most Recent Earnings Dec 31, 2009
Fiscal Year End Mar 31, 2012
Employees 45